Tolterodine
- Generic Name
- Tolterodine
- Brand Names
- Detrol, Detrusitol
- Drug Type
- Small Molecule
- Chemical Formula
- C22H31NO
- CAS Number
- 124937-51-5
- Unique Ingredient Identifier
- WHE7A56U7K
- Background
Tolterodine is an antimuscarinic drug that is used to treat urinary incontinence. Tolterodine acts on M2 and M3 subtypes of muscarinic receptors.
- Indication
For the treatment of overactive bladder (with symptoms of urinary frequency, urgency, or urge incontinence).
- Associated Conditions
- Urinary Urge Incontinence
- Associated Therapies
- -
Pharmacokinetics and Relative Bioavailability Study
- First Posted Date
- 2012-01-31
- Last Posted Date
- 2021-01-27
- Target Recruit Count
- 16
- Registration Number
- NCT01521767
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2021-01-28
- Target Recruit Count
- 11157
- Registration Number
- NCT01488578
Study of Herbmed Plus in Ureteral Stent Discomfort
- Conditions
- Interventions
- First Posted Date
- 2011-05-19
- Last Posted Date
- 2016-01-05
- Lead Sponsor
- Dr .S.B.PATANKAR
- Target Recruit Count
- 140
- Registration Number
- NCT01356355
- Locations
- 🇮🇳
AMAI Charitable Trust's ACE Hospital Pune, Pune, Maharashtra, India
GABAergic Modulation in Pain Transmission in Human: Effect of the GABAA Agonist Clobazam on Peripheral and Central Sensitisation
- Conditions
- Interventions
- First Posted Date
- 2011-02-08
- Last Posted Date
- 2011-12-14
- Lead Sponsor
- University Hospital, Geneva
- Target Recruit Count
- 25
- Registration Number
- NCT01291316
- Locations
- 🇨🇭
University Hospitals, Geneva, Switzerland
STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study
- First Posted Date
- 2010-08-13
- Last Posted Date
- 2010-08-13
- Lead Sponsor
- Inje University
- Target Recruit Count
- 31
- Registration Number
- NCT01181505
Linking Altered Central Pain Processing and Genetic Polymorphism to Drug Efficacy in Chronic Low Back Pain (Predictio)
- Conditions
- Interventions
- First Posted Date
- 2010-08-11
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 150
- Registration Number
- NCT01179828
- Locations
- 🇨🇭
Andreas Siegenthaler, Dep. of Anesthesiolgy and Pain therapy, Bern University Hospital, Switzerland
Effects of Novel Combinations of Tolterodine/Pilocarpine on Pharmacokinetics (PK) and Pharmacodynamics (PD) of Tolterodine in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2015-12-30
- Lead Sponsor
- TheraVida, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01036035
Effects of GABA-a-Agonists on Pain Mechanisms: An Experimental Study in Healthy Volunteers
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2010-08-11
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Target Recruit Count
- 17
- Registration Number
- NCT01011036
- Locations
- 🇨🇭
Dep of Anesthesiology and Pain Therapy, University Hospital Bern, Bern, Switzerland
A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder
- Conditions
- Interventions
- First Posted Date
- 2009-10-29
- Last Posted Date
- 2010-07-27
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 750
- Registration Number
- NCT01004315
- Locations
- 🇯🇵
Japan, Hokkaido,Tohoku,Kanto,Chubu,Kansai,Shikoku,Kyushu, Japan
A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder
- Conditions
- Interventions
- First Posted Date
- 2009-08-26
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 1139
- Registration Number
- NCT00966004
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.